Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734870) titled 'Tirzepatide for Treatment of CCCA' on July 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Johns Hopkins University
Condition:
Central Centrifugal Cicatricial Alopecia (CCCA)
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 23, 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07734870
Disclaimer: Curated by HT Syndication....